Despite a recent 45% rally, I maintain a 'Sell' view on CVS due to its underwhelming execution record and rising leverage ...

As healthcare spending continues to rise and regulatory pressure intensifies, companies like CVS Health CVS find themselves in a complex landscape. However, in spite of these hurdles, the company ...

As healthcare spending continues to rise and regulatory pressure intensifies, companies like CVS Health CVS find themselves ...

We recently published a list of the 10 Best Performing Healthcare Stocks So Far in 2025. In this article, we are going to ...

As of 12/31/2024The holdings listed should not be considered recommendations to purchase or sell a particular security. Equity holdings are grouped to include common shares, depository receipts, ...

In this article, we will look at the 10 Best Performing Healthcare Stocks So Far in 2025.

CVS is fighting to protect its PBM business as Trump and Congress look for ways to take out the pharmacy "middlemen." The S&P 500 hit a new all-time high on Feb. 18. We highlight five stocks in ...

Earnings have fallen but are still strong enough to meet CVS Health's dividend commitment. Management expects adjusted earnings for 2025 to land in a range between $5.75 and $6 per share. That's ...

As of 2:42:37 p.m. EST. Market Open. CVS Health investors will closely examine this week turnaround initiatives spearheaded by new CEO David Joyner and their impact on cost pressures in its health ...